Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Single Ablative Fractional Resurfacing Laser Treatment For Forearm Actinic Keratoses: 6-Month Follow-Up Data From An Intrapatient Comparison Between Treated and Untreated Sites.

Chen R, Wargo JJ, Williams A, Cates E, Spandau DF, Knisely C, Travers JB.

Lasers Surg Med. 2019 Nov 17. doi: 10.1002/lsm.23175. [Epub ahead of print]

PMID:
31736123
2.

Wounding with a microneedling device corrects the inappropriate ultraviolet B radiation response in geriatric skin.

Travers JB, Kemp MG, Weir NM, Cates E, Alkawar AM, Mahajan AS, Spandau DF.

Arch Dermatol Res. 2019 Oct 28. doi: 10.1007/s00403-019-02001-z. [Epub ahead of print]

PMID:
31659432
3.

Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches.

Thyagarajan A, Alshehri MSA, Miller KLR, Sherwin CM, Travers JB, Sahu RP.

Cancers (Basel). 2019 Oct 24;11(11). pii: E1627. doi: 10.3390/cancers11111627. Review.

4.

Quantifying skin photodamage with spatial frequency domain imaging: statistical results.

Travers JB, Poon C, Bihl T, Rinehart B, Borchers C, Rohrbach DJ, Borchers S, Trevino J, Rubin M, Donnelly H, Kellawan K, Carpenter L, Bahl S, Rohan C, Muennich E, Guenthner S, Hahn H, Rkein A, Darst M, Mousdicas N, Cates E, Sunar U.

Biomed Opt Express. 2019 Aug 20;10(9):4676-4683. doi: 10.1364/BOE.10.004676. eCollection 2019 Sep 1.

5.

p38 MAP-kinase inhibitor protects against platelet-activating factor-induced death in mice.

Abhilasha KV, Sumanth MS, Chaithra VH, Jacob SP, Thyagarajan A, Sahu RP, Rajaiah R, Prabhu KS, Kemparaju K, Travers JB, Chen CH, Marathe GK.

Free Radic Biol Med. 2019 Nov 1;143:275-287. doi: 10.1016/j.freeradbiomed.2019.08.019. Epub 2019 Aug 20.

PMID:
31442556
6.

Platelet-Activating Factor as an Effector for Environmental Stressors.

Travers JB.

Handb Exp Pharmacol. 2019 May 14. doi: 10.1007/164_2019_218. [Epub ahead of print]

PMID:
31087194
7.

Breast milk alkylglycerols sustain beige adipocytes through adipose tissue macrophages.

Yu H, Dilbaz S, Coßmann J, Hoang AC, Diedrich V, Herwig A, Harauma A, Hoshi Y, Moriguchi T, Landgraf K, Körner A, Lucas C, Brodesser S, Balogh L, Thuróczy J, Karemore G, Kuefner MS, Park EA, Rapp C, Travers JB, Röszer T.

J Clin Invest. 2019 May 13;129(6):2485-2499. doi: 10.1172/JCI125646. eCollection 2019 May 13.

8.

Use of a Natural Porcine Extracellular Matrix With Negative Pressure Wound Therapy Hastens the Healing Rate in Stage 4 Pressure Ulcers.

Mari W, Younes S, Naqvi J, Issa AA, Oroszi TL, Cool DR, Travers JB, Simman R.

Wounds. 2019 May;31(5):117-122. Epub 2019 Mar 15.

9.

Acute Ethanol Exposure Augments Low-Dose UVB-Mediated Systemic Immunosuppression via Enhanced Production of Platelet-Activating Factor Receptor Agonists.

Travers JB, Weyerbacher J, Ocana JA, Borchers C, Rapp CM, Sahu RP.

J Invest Dermatol. 2019 Jul;139(7):1619-1622. doi: 10.1016/j.jid.2018.11.034. Epub 2019 Jan 23. No abstract available.

PMID:
30682347
10.

Toxic cutaneous responses from inhalant abuse.

Hawash A, Travers JB, Gokce S.

JAAD Case Rep. 2018 Dec 4;5(1):31-33. doi: 10.1016/j.jdcr.2018.10.009. eCollection 2019 Jan. No abstract available.

11.

Spironolactone Depletes the XPB Protein and Inhibits DNA Damage Responses in UVB-Irradiated Human Skin.

Kemp MG, Krishnamurthy S, Kent MN, Schumacher DL, Sharma P, Excoffon KJDA, Travers JB.

J Invest Dermatol. 2019 Feb;139(2):448-454. doi: 10.1016/j.jid.2018.07.039. Epub 2018 Sep 15.

PMID:
30227140
12.

Modulation of inflammatory platelet-activating factor (PAF) receptor by the acyl analogue of PAF.

Chaithra VH, Jacob SP, Lakshmikanth CL, Sumanth MS, Abhilasha KV, Chen CH, Thyagarajan A, Sahu RP, Travers JB, McIntyre TM, Kemparaju K, Marathe GK.

J Lipid Res. 2018 Nov;59(11):2063-2074. doi: 10.1194/jlr.M085704. Epub 2018 Aug 23.

13.

Gain control with A-type potassium current: IA as a switch between divisive and subtractive inhibition.

Goldwyn JH, Slabe BR, Travers JB, Terman D.

PLoS Comput Biol. 2018 Jul 9;14(7):e1006292. doi: 10.1371/journal.pcbi.1006292. eCollection 2018 Jul.

14.

Early assessment of burn severity in human tissue ex vivo with multi-wavelength spatial frequency domain imaging.

Poon C, Sunar U, Rohrbach DJ, Krishnamurthy S, Olsen T, Kent M, Weir NM, Simman R, Travers JB.

Toxicol In Vitro. 2018 Oct;52:251-254. doi: 10.1016/j.tiv.2018.05.015. Epub 2018 Jun 1.

15.

Enhanced Platelet-Activating Factor Synthesis Facilitates Acute and Delayed Effects of Ethanol-Intoxicated Thermal Burn Injury.

Harrison KA, Romer E, Weyerbacher J, Ocana JA, Sahu RP, Murphy RC, Kelly LE, Smith TA, Rapp CM, Borchers C, Cool DR, Li G, Simman R, Travers JB.

J Invest Dermatol. 2018 Nov;138(11):2461-2469. doi: 10.1016/j.jid.2018.04.039. Epub 2018 May 30.

16.

Platelet-Activating Factor-Induced Reduction in Contact Hypersensitivity Responses Is Mediated by Mast Cells via Cyclooxygenase-2-Dependent Mechanisms.

Ocana JA, Romer E, Sahu R, Pawelzik SC, FitzGerald GA, Kaplan MH, Travers JB.

J Immunol. 2018 Jun 15;200(12):4004-4011. doi: 10.4049/jimmunol.1701145. Epub 2018 Apr 25.

17.

An aberrant reaction to Candida albicans antigen used for recalcitrant warts successfully treated with oral prednisone.

La'Pelusa A, Rorex J, Weir NM, Travers JB.

JAAD Case Rep. 2018 Feb 27;4(3):242-244. doi: 10.1016/j.jdcr.2018.01.010. eCollection 2018 Apr. No abstract available.

18.

Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Khan AQ, Travers JB, Kemp MG.

Environ Mol Mutagen. 2018 Jun;59(5):438-460. doi: 10.1002/em.22176. Epub 2018 Feb 21. Review.

19.

Phenotyping acute and chronic atopic dermatitis-like lesions in Stat6VT mice identifies a role for IL-33 in disease pathogenesis.

DaSilva-Arnold SC, Thyagarajan A, Seymour LJ, Yi Q, Bradish JR, Al-Hassani M, Zhou H, Perdue NJ, Nemeth V, Krbanjevic A, Serezani APM, Olson MR, Spandau DF, Travers JB, Kaplan MH, Turner MJ.

Arch Dermatol Res. 2018 Apr;310(3):197-207. doi: 10.1007/s00403-018-1807-y. Epub 2018 Jan 24.

20.

Epidermal PPARγ influences subcutaneous tumor growth and acts through TNF-α to regulate contact hypersensitivity and the acute photoresponse.

Konger RL, Derr-Yellin E, Travers JB, Ocana JA, Sahu RP.

Oncotarget. 2017 Sep 18;8(58):98184-98199. doi: 10.18632/oncotarget.21002. eCollection 2017 Nov 17.

21.

Kitty Litter Dermatitis from-Bromo-2-Nitropropane-1,3-Diol.

Sullenbarger JW, Hensley B, Travers JB.

Skinmed. 2017 Oct 1;15(5):389-390. eCollection 2017.

PMID:
29139375
22.

A computational analysis of signal fidelity in the rostral nucleus of the solitary tract.

Boxwell A, Terman D, Frank M, Yanagawa Y, Travers JB.

J Neurophysiol. 2018 Mar 1;119(3):771-785. doi: 10.1152/jn.00624.2017. Epub 2017 Nov 1.

23.

Noninvasive mesoscopic imaging of actinic skin damage using spatial frequency domain imaging.

Travers JB, Poon C, Rohrbach DJ, Weir NM, Cates E, Hager F, Sunar U.

Biomed Opt Express. 2017 May 23;8(6):3045-3052. doi: 10.1364/BOE.8.003045. eCollection 2017 Jun 1.

24.

Poly-ADP ribose polymerase-14 limits severity of allergic skin disease.

Krishnamurthy P, Da-Silva-Arnold S, Turner MJ, Travers JB, Kaplan MH.

Immunology. 2017 Nov;152(3):451-461. doi: 10.1111/imm.12782. Epub 2017 Jul 27.

25.

Impact of Age and Insulin-Like Growth Factor-1 on DNA Damage Responses in UV-Irradiated Human Skin.

Kemp MG, Spandau DF, Travers JB.

Molecules. 2017 Feb 26;22(3). pii: E356. doi: 10.3390/molecules22030356. Review.

26.

UVB-generated Microvesicle Particles: A Novel Pathway by Which a Skin-specific Stimulus Could Exert Systemic Effects.

Fahy K, Liu L, Rapp CM, Borchers C, Bihl JC, Chen Y, Simman R, Travers JB.

Photochem Photobiol. 2017 Jul;93(4):937-942. doi: 10.1111/php.12703. Epub 2017 Mar 2. Review.

27.

Insulin-like Growth Factor 1 Receptor Signaling Is Required for Optimal ATR-CHK1 Kinase Signaling in Ultraviolet B (UVB)-irradiated Human Keratinocytes.

Kemp MG, Spandau DF, Simman R, Travers JB.

J Biol Chem. 2017 Jan 27;292(4):1231-1239. doi: 10.1074/jbc.M116.765883. Epub 2016 Dec 15.

28.

How Wounding via Lasers Has Potential Photocarcinogenic Preventative Effects via Dermal Remodeling.

Krbanjevic A, Travers JB, Spandau DF.

Curr Dermatol Rep. 2016 Sep;5(3):222-227. Epub 2016 Jul 7.

29.

Increased Th2 activity and diminished skin barrier function cooperate in allergic skin inflammation.

Sehra S, Krishnamurthy P, Koh B, Zhou HM, Seymour L, Akhtar N, Travers JB, Turner MJ, Kaplan MH.

Eur J Immunol. 2016 Nov;46(11):2609-2613. doi: 10.1002/eji.201646421. Epub 2016 Aug 29.

30.

Multilevel symmetric neuropathic pruritus (MSNP) presenting as recalcitrant "generalized" pruritus.

Ward RE, Veerula VL, Ezra N, Travers JB, Mousdicas N.

J Am Acad Dermatol. 2016 Oct;75(4):774-781. doi: 10.1016/j.jaad.2016.05.027. Epub 2016 Jul 27.

PMID:
27476106
31.

Insulin-like growth factor-1 receptor regulates repair of ultraviolet B-induced DNA damage in human keratinocytes in vivo.

Loesch MM, Collier AE, Southern DH, Ward RE, Tholpady SS, Lewis DA, Travers JB, Spandau DF.

Mol Oncol. 2016 Oct;10(8):1245-54. doi: 10.1016/j.molonc.2016.06.002. Epub 2016 Jun 16.

32.

Inhibitory modulation of optogenetically identified neuron subtypes in the rostral solitary nucleus.

Chen Z, Travers SP, Travers JB.

J Neurophysiol. 2016 Aug 1;116(2):391-403. doi: 10.1152/jn.00168.2016. Epub 2016 May 4.

33.

Analyses of Endothelial Cells and Endothelial Progenitor Cells Released Microvesicles by Using Microbead and Q-dot Based Nanoparticle Tracking Analysis.

Wang J, Zhong Y, Ma X, Xiao X, Cheng C, Chen Y, Iwuchukwu I, Gaines KJ, Zhao B, Liu S, Travers JB, Bihl JC, Chen Y.

Sci Rep. 2016 Apr 20;6:24679. doi: 10.1038/srep24679.

34.

Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation.

Sehra S, Serezani APM, Ocaña JA, Travers JB, Kaplan MH.

J Invest Dermatol. 2016 Jul;136(7):1429-1437. doi: 10.1016/j.jid.2016.03.019. Epub 2016 Mar 25.

35.

Examining the differences in current regulatory processes for sunscreens and proposed safety assessment paradigm.

Sargent EV, Travers JB.

Regul Toxicol Pharmacol. 2016 Aug;79:125-141. doi: 10.1016/j.yrtph.2016.03.008. Epub 2016 Mar 22.

PMID:
27016397
36.

Radiation therapy generates platelet-activating factor agonists.

Sahu RP, Harrison KA, Weyerbacher J, Murphy RC, Konger RL, Garrett JE, Chin-Sinex HJ, Johnston ME 2nd, Dynlacht JR, Mendonca M, McMullen K, Li G, Spandau DF, Travers JB.

Oncotarget. 2016 Apr 12;7(15):20788-800. doi: 10.18632/oncotarget.7878.

37.

UVB Generates Microvesicle Particle Release in Part Due to Platelet-activating Factor Signaling.

Bihl JC, Rapp CM, Chen Y, Travers JB.

Photochem Photobiol. 2016 May;92(3):503-6. doi: 10.1111/php.12577. Epub 2016 Mar 14.

38.

Effects of high-fat diet and gastric bypass on neurons in the caudal solitary nucleus.

Boxwell AJ, Chen Z, Mathes CM, Spector AC, Le Roux CW, Travers SP, Travers JB.

Physiol Behav. 2015 Dec 1;152(Pt B):329-39. doi: 10.1016/j.physbeh.2015.07.025. Epub 2015 Jul 26.

39.

Systemic chemotherapy is modulated by platelet-activating factor-receptor agonists.

Sahu RP, Ferracini M, Travers JB.

Mediators Inflamm. 2015;2015:820543. doi: 10.1155/2015/820543. Epub 2015 Apr 2.

40.

Important implications and new uses of ablative lasers in dermatology: fractional carbon dioxide laser prevention of skin cancer.

Jagdeo JR, Brody NI, Spandau DF, Travers JB.

Dermatol Surg. 2015 Mar;41(3):387-9. doi: 10.1097/DSS.0000000000000308. No abstract available.

PMID:
25742561
41.

Trichodysplasia spinulosa in gorlin syndrome treated with vismodegib-reply.

Richey JD, Katona T, Travers JB.

JAMA Dermatol. 2015 Apr;151(4):459. doi: 10.1001/jamadermatol.2014.4388. No abstract available.

42.

Topical application of a platelet activating factor receptor agonist suppresses phorbol ester-induced acute and chronic inflammation and has cancer chemopreventive activity in mouse skin.

Sahu RP, Rezania S, Ocana JA, DaSilva-Arnold SC, Bradish JR, Richey JD, Warren SJ, Rashid B, Travers JB, Konger RL.

PLoS One. 2014 Nov 6;9(11):e111608. doi: 10.1371/journal.pone.0111608. eCollection 2014.

43.

Chemotherapeutic agents subvert tumor immunity by generating agonists of platelet-activating factor.

Sahu RP, Ocana JA, Harrison KA, Ferracini M, Touloukian CE, Al-Hassani M, Sun L, Loesch M, Murphy RC, Althouse SK, Perkins SM, Speicher PJ, Tyler DS, Konger RL, Travers JB.

Cancer Res. 2014 Dec 1;74(23):7069-78. doi: 10.1158/0008-5472.CAN-14-2043. Epub 2014 Oct 10.

44.

Skin resurfacing procedures: new and emerging options.

Loesch MM, Somani AK, Kingsley MM, Travers JB, Spandau DF.

Clin Cosmet Investig Dermatol. 2014 Aug 28;7:231-41. doi: 10.2147/CCID.S50367. eCollection 2014. Review.

45.

Development of trichodysplasia spinulosa: case report of a patient with Gorlin syndrome treated with vismodegib.

Richey JD, Graham TA, Katona T, Travers JB.

JAMA Dermatol. 2014 Sep;150(9):1016-8. doi: 10.1001/jamadermatol.2013.9322. No abstract available.

PMID:
25054782
46.

Topical photodynamic therapy induces systemic immunosuppression via generation of platelet-activating factor receptor ligands.

Ferracini M, Sahu RP, Harrison KA, Waeiss RA, Murphy RC, Jancar S, Konger RL, Travers JB.

J Invest Dermatol. 2015 Jan;135(1):321-323. doi: 10.1038/jid.2014.313. Epub 2014 Jul 22. No abstract available.

47.

Toxic interaction between Th2 cytokines and Staphylococcus aureus in atopic dermatitis.

Travers JB.

J Invest Dermatol. 2014 Aug;134(8):2069-2071. doi: 10.1038/jid.2014.122.

48.

Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis.

Hackler PC, Reuss S, Konger RL, Travers JB, Sahu RP.

Cancer Growth Metastasis. 2014 Jun 19;7:27-32. doi: 10.4137/CGM.S14501. eCollection 2014.

49.

STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis.

Turner MJ, DaSilva-Arnold S, Luo N, Hu X, West CC, Sun L, Hill C, Bradish J, Kaplan MH, Travers JB, Sun Y.

Invest Ophthalmol Vis Sci. 2014 May 20;55(6):3803-8. doi: 10.1167/iovs.13-13685.

50.

Adrenoreceptor modulation of oromotor pathways in the rat medulla.

Nasse JS, Travers JB.

J Neurophysiol. 2014 Aug 1;112(3):580-93. doi: 10.1152/jn.00091.2014. Epub 2014 May 7.

Supplemental Content

Loading ...
Support Center